137 related articles for article (PubMed ID: 2683192)
1. Platelet size affects both micro- and macro-aggregation: contributions of platelet number, volume fraction and cell surface.
Wong T; Pedvis L; Frojmovic M
Thromb Haemost; 1989 Sep; 62(2):733-41. PubMed ID: 2683192
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
Pedvis LG; Wong T; Frojmovic MM
Thromb Haemost; 1988 Apr; 59(2):323-8. PubMed ID: 2455359
[TBL] [Abstract][Full Text] [Related]
3. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
4. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
5. Effects of any epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets.
di Minno G; Bertelé V; Bianchi L; Barbieri B; Cerletti C; Dejana E; de Gaetano G; Silver MJ
Thromb Haemost; 1981 Apr; 45(2):103-6. PubMed ID: 6266066
[TBL] [Abstract][Full Text] [Related]
6. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood.
Heptinstall S; May JA; Glenn JR; Sanderson HM; Dickinson JP; Wilcox RG
Thromb Haemost; 1995 Nov; 74(5):1310-5. PubMed ID: 8607115
[TBL] [Abstract][Full Text] [Related]
7. Platelet size as a determinant of platelet function.
Thompson CB; Jakubowski JA; Quinn PG; Deykin D; Valeri CR
J Lab Clin Med; 1983 Feb; 101(2):205-13. PubMed ID: 6822760
[TBL] [Abstract][Full Text] [Related]
8. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
9. Platelet activation induced by a stable analogue of endoperoxides (U46619).
Zatta A; Prosdocimi M
Thromb Haemost; 1989 Apr; 61(2):328-9. PubMed ID: 2526389
[No Abstract] [Full Text] [Related]
10. Identification of platelet inhibitor present in the melon (Cucurbitacea cucumis melo).
Altman R; Rouvier J; Weisenberger H
Thromb Haemost; 1985 Jun; 53(3):312-3. PubMed ID: 3931281
[TBL] [Abstract][Full Text] [Related]
11. Maternal and fetal platelet activation in normal pregnancy.
Nicolini U; Guarneri D; Gianotti GA; Campagnoli C; Crosignani PG; Gatti L
Obstet Gynecol; 1994 Jan; 83(1):65-9. PubMed ID: 8272311
[TBL] [Abstract][Full Text] [Related]
12. Diversity of signaling underlying responses mediated by selective activation of the platelet thromboxane A2 (TXA2) receptor; pharmacological and kinetic studies in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003 Sep; 14(6):359-74. PubMed ID: 14602550
[TBL] [Abstract][Full Text] [Related]
13. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS).
Milton JG; Frojmovic MM; Tang SS; White JG
Am J Pathol; 1984 Feb; 114(2):336-45. PubMed ID: 6696046
[TBL] [Abstract][Full Text] [Related]
15. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K
Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747
[TBL] [Abstract][Full Text] [Related]
16. How can we inhibit 5-HT-induced platelet aggregation and why should we bother?
Heptinstall S; Bevan J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):475-8. PubMed ID: 2465956
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1982 Jul; 222(1):276-81. PubMed ID: 7086705
[TBL] [Abstract][Full Text] [Related]
18. Free platelet count and size distribution during C1q inhibition of collagen-induced platelet aggregation.
Csako G; Suba EA
Thromb Haemost; 1987 Aug; 58(2):682-5. PubMed ID: 3499680
[TBL] [Abstract][Full Text] [Related]
19. Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators.
Fourcade O; Simon MF; Litt L; Samii K; Chap H
Anesth Analg; 2004 Aug; 99(2):393-8, table of contents. PubMed ID: 15271713
[TBL] [Abstract][Full Text] [Related]
20. Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation.
Nunn B
Thromb Res; 1983 Sep; 31(5):657-63. PubMed ID: 6648898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
